Scotiabank Initiates Coverage On EyePoint Pharmaceuticals With Sector Outperform Rating, Announces Price Target of $18
Scotiabank Initiates Coverage On EyePoint Pharmaceuticals With Sector Outperform Rating, Announces Price Target of $18
加拿大豐業銀行開始對眼點製藥進行覆蓋，並給出板塊表現評級，宣佈目標股價爲18美元
Scotiabank analyst Greg Harrison initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Sector Outperform rating and announces Price Target of $18.
加拿大皇家銀行 分析師 Greg Harrison 發起對eyepoint pharmaceuticals（納斯達克股票代碼：EYPT）的覆蓋，給予該公司板塊外表現評級，並公佈目標價格爲18美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間